Talon Therapeutics' P2P Acquisition

Talon Therapeutics raised a round of funding on July 18, 2013. Investors include Spectrum Pharmaceuticals.

Talon Therapeutics is a biopharmaceutical company that develops and commercializes new and differentiated cancer therapies. Its lead product includes Marqibo, which is a novel sphingomyelin/cholestero…

Articles about Talon Therapeutics' P2P Acquisition: